newsmaker

Finch Therapeutics Reclaims Full Control of Fin-524 and Fin-525: Promising Microbiome Products for IBD Development

Finch Therapeutics Regains Full Rights to FIN-524 and FIN-525 Targeted Micro… SOMERVILLE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH) Finch Therapeutics, a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, has announced that it…

Read More

Attention Investors: Bronstein, Gewirtz & Grossman LLC Announces Class Action Against Miniso Group Holding Limited (MNSO) – Take Action Now!

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies MINISO Group Holding Limited (MNSO) Investors of Class Action and Possible Impact Background On August 23, 2022, Bronstein, Gewirtz & Grossman, LLC, a leading investor protection law firm, announced that a class action lawsuit has been filed against MINISO Group Holding Limited (“MINISO” or “the Company”) (NYSE:…

Read More

GBTS Receives Notice of Publication for Facial and Body Recognition Patent Application: A Breakthrough in Technology!

GBT’s Facial and Body Recognition Patent Application Received a Notice of Publication Introduction Have you ever watched a sci-fi movie and wondered if the technology shown is actually possible in real life? Well, advances in machine learning driven image identification and recognition systems are making futuristic tech a reality. GBT Technologies Inc. recently received a…

Read More

Unlimint Takes Banking to the Next Level with Exciting New BaaS Solution!

Unlimint Launches Unlimint Banking and Cards Product Introduction London-based Unlimint, previously known as Cardpay, announced on Tuesday the launch of Unlimint Banking and Cards (UBC), which is the fintech’s banking-as-a-service (BaaS) product. What is Unlimint Banking and Cards (UBC)? The new product is offering payment accounts along with card issuing and processing solutions to businesses…

Read More

Emerald Health Therapeutics Shareholders Approve Plan of Arrangement with Skye Bioscience: A Promising Partnership in the World of Biotechnology

Skye Bioscience Reports that Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement San Diego, California, Aug. 19, 2022 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the shareholders of Emerald Health Therapeutics, Inc. (“Emerald”…

Read More

Say Goodbye to Boring Properties: Laredo Petroleum Sells Howard County Assets for $110 Million!

Exciting News from Laredo Petroleum! Proceeds To Support Equity and Debt Repurchase Programs TULSA, OK, Aug. 17, 2022 (GLOBE NEWSWIRE) — Laredo Petroleum, Inc. (NYSE: LPI) (“Laredo” or the “Company”) today announced the signing of a purchase and sale agreement to divest certain non-operated properties in Howard County for $110 million, subject to customary closing…

Read More